|
rac,cis-[2-(2,4-二氯苯基)-2-(1H-1,2,4-三唑-1-基甲基)-1,3-二氧戊环-4-基]甲基甲硫
|
R185985-5g
|
≥97% |
67914-86-7 |
5g
|
¥ 76.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
rac,cis-[2-(2,4-二氯苯基)-2-(1H-1,2,4-三唑-1-基甲基)-1,3-二氧戊环-4-基]甲基甲硫
|
R185985-1g
|
≥97% |
67914-86-7 |
1g
|
¥ 38.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Boc-1-氨基茚满-1-羧酸
|
R182774-250mg
|
≥97% |
214139-26-1 |
250mg
|
¥ 70.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-1-(2-氟苯基)乙胺
|
R182303-50mg
|
≥95% |
185545-90-8 |
50mg
|
¥ 25.9
|
现货 |
|
0 |
阿拉丁 |
|
(4R,6S)-5,6-二氢-4-羟基-6-甲基噻吩并[2,3-b]噻喃-7,7-二氧化物
|
R181570-1g
|
≥98% |
147128-77-6 |
1g
|
¥ 87.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-1-Cbz-β-脯氨酸乙酯
|
R180937-1g
|
≥96% |
1263078-10-9 |
1g
|
¥ 1851.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-4-苄基吗啉-3-羧酸甲酯
|
R180484-250mg
|
≥95% |
1235134-83-4 |
250mg
|
¥ 204.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-4-羟甲基-2,2-二甲基恶唑烷-3-羧酸叔丁酯
|
R179314-250mg
|
≥96% |
108149-63-9 |
250mg
|
¥ 65.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,3R)-3-{[[(叔丁氧基)羰基]氨基}环戊烷-1-羧酸
|
R176599-50mg
|
≥97% |
489446-85-7 |
50mg
|
¥ 88.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R,5S)-5-(羟甲基)吡咯烷-3-醇盐酸盐
|
R176579-50mg
|
≥97% |
478922-47-3 |
50mg
|
¥ 24.9
|
现货 |
|
0 |
阿拉丁 |
|
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐
|
R176323-5mg
|
≥97% |
376608-71-8 |
5mg
|
¥ 29.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2R)-2-苄基-3-{[[(叔丁氧基)羰基]氨基}丙酸
|
R175934-50mg
|
≥97% |
262301-38-2 |
50mg
|
¥ 405.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,3R)-3-氨基环戊烷-1-羧酸盐酸盐
|
R174650-25mg
|
≥97% |
1625682-44-1 |
25mg
|
¥ 235.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Ravoxertinib,ERK 抑制剂
|
R174276-5mg
|
Moligand™, ≥97% |
1453848-26-4 |
5mg
|
¥ 718.9
|
现货 |
|
0 |
阿拉丁 |
|
2-[((3R)-吡咯烷-3-基]丙-2-醇
|
R172894-1g
|
≥97% |
1245649-03-9 |
1g
|
¥ 1871.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[((3R)-吡咯烷-3-基]丙-2-醇
|
R172894-250mg
|
≥97% |
1245649-03-9 |
250mg
|
¥ 1139.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2R)-1-甲基吡咯烷-2-羧酸水合物
|
R172659-5g
|
≥97% |
1217447-61-4 |
5g
|
¥ 561.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
瑞博西利
|
R172598-50mg
|
Moligand™, ≥98% |
1211441-98-3 |
50mg
|
¥ 445.9
|
现货 |
|
0 |
阿拉丁 |
|
鲁索利替尼
|
R171967-10mg
|
≥98% |
1092939-17-7 |
10mg
|
¥ 211.9
|
现货 |
|
0 |
阿拉丁 |
|
活性艳蓝KN-R
|
R169089-5g
|
|
2580-78-1 |
5g
|
¥ 56.9
|
现货 |
|
0 |
阿拉丁 |
|
Ro 61-8048,竞争性犬尿氨酸3-单加氧酶(KMO)抑制剂
|
R168334-10mg
|
≥98%(HPLC) |
199666-03-0 |
10mg
|
¥ 319.9
|
现货 |
|
0 |
阿拉丁 |
|
三苯基乙酸铑(II)二聚体(Rh2(TPA)4)
|
R167247-10mg
|
≥99% |
142214-04-8 |
10mg
|
¥ 139.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-MG132,20S蛋白酶体抑制剂
|
R166528-5mg
|
≥98% |
1211877-36-9 |
5mg
|
¥ 439.9
|
现货 |
|
0 |
阿拉丁 |
|
七乙酸芸香糖酯
|
R160966-250mg
|
≥98%(GC) |
29202-64-0 |
250mg
|
¥ 1392.9
|
期货,请咨询 |
|
0 |
阿拉丁 |